Purdue Pharma to stay in business as bankruptcy unfolds


Save Story
Leer en español

Estimated read time: Less than a minute

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

WHITE PLAINS, N.Y. (AP) — A judge has cleared the way for OxyContin maker Purdue Pharma to stay in business while it pursues bankruptcy protection and settlement of more than 2,600 lawsuits filed over the opioid crisis.

Purdue lawyers secured permission Tuesday for the company to maintain business as usual. That includes paying employees and vendors, supplying pills to distributors, and keeping current on taxes and insurance.

Purdue Pharma declared bankruptcy late Sunday. Its continued viability is key to the company's settlement offer.

Under the proposal, the family that owns Purdue would turn the company over to a trust controlled by the very entities that are suing it.

About half the states support the offer. It could be worth up to $12 billion over time.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Most recent Business stories

Related topics

Business
MICHAEL R. SISAK

    STAY IN THE KNOW

    Get informative articles and interesting stories delivered to your inbox weekly. Subscribe to the KSL.com Trending 5.
    By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Policy.

    KSL Weather Forecast